Ironwood Pharmaceuticals (IRWD) Payables (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Payables across 17 years of filings, most recently posting $911000.0 for Q2 2026.

• In Q2 2026, Payables fell 34.41% year-over-year to $911000.0; the TTM figure through Jun 2026 stood at $911000.0 (down 34.41% YoY), while the FY2025 annual figure was $2.9 million, up 36.25% from the prior year.
• Payables came in at $911000.0 for Q2 2026 at Ironwood Pharmaceuticals, down from $3.2 million in the prior quarter.
• In the past five years, Payables ranged from a high of $7.8 million in Q4 2023 to a low of $118000.0 in Q1 2023.
• Average Payables over 5 years is $2.7 million, with a median of $2.5 million recorded in 2024.
• Year-over-year, Payables plunged 77.82% in 2023 and soared 5172.88% in 2024.
• Over 5 years, Payables stood at $483000.0 in 2022, then soared by 1521.12% to $7.8 million in 2023, then tumbled by 72.84% to $2.1 million in 2024, then surged by 36.25% to $2.9 million in 2025, then slumped by 68.56% to $911000.0 in 2026.
• Per Business Quant data, the three most recent Payables figures were $911000.0 in Q2 2026, $3.2 million in Q1 2026, and $2.9 million in Q4 2025.